Medical Scheme Financial Pressure Escalates As Costs Soar

Medical scheme financial pressure intensifies as healthcare costs, an ageing population, and a R11.64bn operating deficit squeeze the sector.

Excessive Dialysis Product Pricing: Adcock Ingram Referred

The excessive Dialysis Product Pricing case targets Adcock Ingram, with a possible 10% turnover penalty and wider renal care cost impacts.